Ontology type: schema:ScholarlyArticle
2010-06-29
AUTHORSPaul M. McKie, S. Jeson Sangaralingham, John C. Burnett
ABSTRACTThe natriuretic peptide (NP) family consists of structurally similar, although physiologically distinct, peptides that play an important role in cardiorenal homeostasis. CD-NP is a novel chimeric natriuretic peptide developed by the Mayo Clinic, in which the 15-amino acid COOH-terminus of dendroaspis NP is fused to C-type NP. CD-NP is a dual activator of NP receptors A and B, and therefore, possesses the strong antiproliferative and antifibrotic properties of C-type NP with the potent natriuretic, diuretic, and aldosterone-inhibiting properties of dendroaspis NP. CD-NP has favorable cardiorenal properties when compared to recombinant B-type NP (nesiritide), including preservation of glomerular filtration rate with minimal blood pressure-lowering effects. Thus, CD-NP has emerged as an appealing novel therapeutic strategy for heart failure. The endogenous NP system, the development rationale for CD-NP, as well as in vitro, animal, and human studies and future directions will be reviewed. More... »
PAGES93-99
http://scigraph.springernature.com/pub.10.1007/s11897-010-0016-6
DOIhttp://dx.doi.org/10.1007/s11897-010-0016-6
DIMENSIONShttps://app.dimensions.ai/details/publication/pub.1022530445
PUBMEDhttps://www.ncbi.nlm.nih.gov/pubmed/20582736
JSON-LD is the canonical representation for SciGraph data.
TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT
[
{
"@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json",
"about": [
{
"id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11",
"inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/",
"name": "Medical and Health Sciences",
"type": "DefinedTerm"
},
{
"id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1102",
"inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/",
"name": "Cardiorespiratory Medicine and Haematology",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Animals",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Antihypertensive Agents",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Chimera",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Diuretics",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Drug Design",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Elapid Venoms",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Glomerular Filtration Rate",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Heart Failure",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Humans",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Intercellular Signaling Peptides and Proteins",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Kidney",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Natriuretic Peptide, C-Type",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Peptides",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Receptors, Guanylate Cyclase-Coupled",
"type": "DefinedTerm"
}
],
"author": [
{
"affiliation": {
"alternateName": "Cardiorenal Research Laboratory, Division of Cardiovascular Disease, Mayo Clinic and Foundation, 200 First Street Southwest, 55905, Rochester, MN, USA",
"id": "http://www.grid.ac/institutes/grid.66875.3a",
"name": [
"Cardiorenal Research Laboratory, Division of Cardiovascular Disease, Mayo Clinic and Foundation, 200 First Street Southwest, 55905, Rochester, MN, USA"
],
"type": "Organization"
},
"familyName": "McKie",
"givenName": "Paul M.",
"id": "sg:person.01271304603.22",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01271304603.22"
],
"type": "Person"
},
{
"affiliation": {
"alternateName": "Cardiorenal Research Laboratory, Division of Cardiovascular Disease, Mayo Clinic and Foundation, 200 First Street Southwest, 55905, Rochester, MN, USA",
"id": "http://www.grid.ac/institutes/grid.66875.3a",
"name": [
"Cardiorenal Research Laboratory, Division of Cardiovascular Disease, Mayo Clinic and Foundation, 200 First Street Southwest, 55905, Rochester, MN, USA"
],
"type": "Organization"
},
"familyName": "Sangaralingham",
"givenName": "S. Jeson",
"id": "sg:person.01032132346.11",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01032132346.11"
],
"type": "Person"
},
{
"affiliation": {
"alternateName": "Cardiorenal Research Laboratory, Division of Cardiovascular Disease, Mayo Clinic and Foundation, 200 First Street Southwest, 55905, Rochester, MN, USA",
"id": "http://www.grid.ac/institutes/grid.66875.3a",
"name": [
"Cardiorenal Research Laboratory, Division of Cardiovascular Disease, Mayo Clinic and Foundation, 200 First Street Southwest, 55905, Rochester, MN, USA"
],
"type": "Organization"
},
"familyName": "Burnett",
"givenName": "John C.",
"id": "sg:person.01001266776.01",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01001266776.01"
],
"type": "Person"
}
],
"citation": [
{
"id": "sg:pub.10.1007/s11897-008-0016-y",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1038509334",
"https://doi.org/10.1007/s11897-008-0016-y"
],
"type": "CreativeWork"
}
],
"datePublished": "2010-06-29",
"datePublishedReg": "2010-06-29",
"description": "The natriuretic peptide (NP) family consists of structurally similar, although physiologically distinct, peptides that play an important role in cardiorenal homeostasis. CD-NP is a novel chimeric natriuretic peptide developed by the Mayo Clinic, in which the 15-amino acid COOH-terminus of dendroaspis NP is fused to C-type NP. CD-NP is a dual activator of NP receptors A and B, and therefore, possesses the strong antiproliferative and antifibrotic properties of C-type NP with the potent natriuretic, diuretic, and aldosterone-inhibiting properties of dendroaspis NP. CD-NP has favorable cardiorenal properties when compared to recombinant B-type NP (nesiritide), including preservation of glomerular filtration rate with minimal blood pressure-lowering effects. Thus, CD-NP has emerged as an appealing novel therapeutic strategy for heart failure. The endogenous NP system, the development rationale for CD-NP, as well as in vitro, animal, and human studies and future directions will be reviewed.",
"genre": "article",
"id": "sg:pub.10.1007/s11897-010-0016-6",
"isAccessibleForFree": false,
"isPartOf": [
{
"id": "sg:journal.1033049",
"issn": [
"1546-9530",
"1546-9549"
],
"name": "Current Heart Failure Reports",
"publisher": "Springer Nature",
"type": "Periodical"
},
{
"issueNumber": "3",
"type": "PublicationIssue"
},
{
"type": "PublicationVolume",
"volumeNumber": "7"
}
],
"keywords": [
"C-type NP",
"dendroaspis NP",
"blood pressure-lowering effect",
"aldosterone-inhibiting properties",
"pressure-lowering effect",
"particulate guanylyl cyclase receptors",
"glomerular filtration rate",
"novel therapeutic strategies",
"natriuretic peptide family",
"B-type NP",
"cardiorenal homeostasis",
"heart failure",
"natriuretic peptide",
"guanylyl cyclase receptors",
"cardiorenal disease",
"antifibrotic properties",
"filtration rate",
"Mayo Clinic",
"therapeutic strategies",
"human studies",
"peptide activator",
"cyclase receptors",
"peptide family",
"dual activator",
"clinic",
"activator",
"peptides",
"disease",
"important role",
"receptors",
"vitro",
"homeostasis",
"animals",
"future directions",
"failure",
"rationale",
"NP system",
"CdS NPs",
"study",
"role",
"rate",
"preservation",
"effect",
"acid",
"family",
"strategies",
"development rationale",
"terminus",
"system",
"NPs",
"properties",
"direction"
],
"name": "CD-NP: An Innovative Designer Natriuretic Peptide Activator of Particulate Guanylyl Cyclase Receptors for Cardiorenal Disease",
"pagination": "93-99",
"productId": [
{
"name": "dimensions_id",
"type": "PropertyValue",
"value": [
"pub.1022530445"
]
},
{
"name": "doi",
"type": "PropertyValue",
"value": [
"10.1007/s11897-010-0016-6"
]
},
{
"name": "pubmed_id",
"type": "PropertyValue",
"value": [
"20582736"
]
}
],
"sameAs": [
"https://doi.org/10.1007/s11897-010-0016-6",
"https://app.dimensions.ai/details/publication/pub.1022530445"
],
"sdDataset": "articles",
"sdDatePublished": "2022-08-04T16:58",
"sdLicense": "https://scigraph.springernature.com/explorer/license/",
"sdPublisher": {
"name": "Springer Nature - SN SciGraph project",
"type": "Organization"
},
"sdSource": "s3://com-springernature-scigraph/baseset/20220804/entities/gbq_results/article/article_521.jsonl",
"type": "ScholarlyArticle",
"url": "https://doi.org/10.1007/s11897-010-0016-6"
}
]Download the RDF metadata as: json-ld nt turtle xml License info
JSON-LD is a popular format for linked data which is fully compatible with JSON.
curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/s11897-010-0016-6'
N-Triples is a line-based linked data format ideal for batch operations.
curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/s11897-010-0016-6'
Turtle is a human-readable linked data format.
curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/s11897-010-0016-6'
RDF/XML is a standard XML format for linked data.
curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/s11897-010-0016-6'
This table displays all metadata directly associated to this object as RDF triples.
187 TRIPLES
21 PREDICATES
92 URIs
83 LITERALS
21 BLANK NODES